The goal of this project is to generate data and develop a statistical sampling and analysis strategy to aid FDA/CDER policy in drafting data-based guidance in support of the use of appropriate statistical tools and standards.
Specifically, the development of standards for statistical methods
credit:
suitable for lot release which could be used to drive industry towards increased product and process understanding throughout the lifecycle of a product.
The project will provide data, sampling and data analysis approaches to inform for the agency and the human pharmaceutical industry to advance the development of risk- and science-based standards.
These projects could be split into subsets by product type, process type, manufacturing complexity and/or therapeutic index to facilitate understanding.